Eden Research PLC has received authorization in Portugal for its first product, Mevalone (previously referred to as “3AEY”). The Portuguese authorities have issued “Authorisation for Sale” number 1012 covering the use of Mevalone for the control of botrytis (grey mould) on grapes. Mevalone will be marketed in Portugal by Eden’s partner, K. & N. Efthymiadis S.A.
Mevalone es un fungicida a base de terpenos que ataca a Botrytis, una enfermedad fúngica generalizada que causa moho gris en muchas frutas y verduras, lo que lleva a la rápida pérdida de cultivos de valor comercial.
La aprobación es un hito importante para Eden y otorga a la Compañía acceso a otro de los principales productores de uva europeos. Mevalone, vendido con diferentes nombres comerciales en diferentes países, ya ha obtenido la aprobación en varios países, incluidos España, Italia, Kenia, Malta, Grecia, Bulgaria y, sobre todo recientemente, Francia. Además, Mevalone ya ha tenido un éxito comercial significativo en muchos de estos mercados.
Sean Smith, Chief Executive Officer of Eden, commented: “We are delighted to announce that we have gained authorisation for the sale and use of Mevalone in Portugal, further-increasing Eden’s geographic footprint. Together with Italy, France and Spain we now operate in the four largest grape producing countries in Europe, and we continue to expand into additional countries worldwide.
“Botrytis has the potential to destroy up to 30% of a vineyard in a matter of days. Consequently Mevalone plays a very important role in the treatment of this disease. This approval from the Portuguese authorities opens up significant opportunities for additional crops in Portugal through minor and/or emergency use label extensions. Italy recently received emergency authorisation for the use of Mevalone on pomegranate, and we expect to realise further extensions in many current and new territories.
“Today’s announcement is an important commercial opportunity for Eden and we are pleased to be working with our partner, K. & N. Efthymiadis S.A., to develop the Company’s presence in Portugal. In addition, it is a positive indicator of the regulatory progress Eden is making and we look forward to further approvals in due course.”
Eden informará sus resultados provisionales para los seis meses que terminan el 29 de septiembre de 2017.